These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12749452)

  • 21. [Hormone profile and follicle development in ovarian stimulation treatment for in vitro fertilization. II. Prolactin, estradiol and progesterone profile].
    Sudik R; Fliess FR; Kunkel S
    Zentralbl Gynakol; 1989; 111(9):567-80. PubMed ID: 2500795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the efficacy and safety of a new recombinant human follicle-stimulating hormone (DA-3801) with follitropin-alpha (Gonal-F) in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology.
    Moon SY; Choi YS; Ku SY; Kim SH; Choi YM; Kang IS; Kim CH
    J Obstet Gynaecol Res; 2007 Jun; 33(3):305-15. PubMed ID: 17578360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of recombinant human follicle-stimulating hormone in patients undergoing
    Hu L; Zhang S; Quan S; Lv J; Qian W; Huang Y; Lu W; Sun Y
    Aging (Albany NY); 2020 Mar; 12(6):4918-4930. PubMed ID: 32209728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.
    Dahan MH; Agdi M; Shehata F; Son W; Tan SL
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():70-3. PubMed ID: 24314801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of low-dose corticoid administration (prednisolone 7.5 mg) on the quality of gonadotropin-induced cycle stimulation].
    Würfel W; von Hertwig I; Steck T; Albert P
    Arch Gynecol Obstet; 1989; 245(1-4):854-8. PubMed ID: 2529826
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
    Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The significance of the ratio in follicle-stimulating hormone and luteinizing hormone in induction of multiple follicular growth.
    Bernardus RE; Jones GS; Acosta AA; Garcia JE; Liu HC; Jones DL; Rosenwaks Z
    Fertil Steril; 1985 Mar; 43(3):373-8. PubMed ID: 3920087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant follicle stimulating hormone in in-vitro fertilization treatment-clinical experience with follitropin alpha and follitropin beta.
    Harlin J; Csemiczky G; Wramsby H; Fried G
    Hum Reprod; 2000 Feb; 15(2):239-44. PubMed ID: 10655291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: implications for implantation potential.
    Balasch J; Fábregues F; Creus M; Peñarrubia J; Vidal E; Carmona F; Puerto B; Vanrell JA
    J Assist Reprod Genet; 2000 Jan; 17(1):20-7. PubMed ID: 10754779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment.
    Yong PY; Brett S; Baird DT; Thong KJ
    Fertil Steril; 2003 Feb; 79(2):308-15. PubMed ID: 12568839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the "follicle-stimulating hormone window" combined with the gonadotropin-releasing hormone antagonist cetrorelix.
    de Jong D; Macklon NS; Fauser BC
    Fertil Steril; 2000 May; 73(5):1051-4. PubMed ID: 10785238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gonadotropin-releasing hormone and its analogues: applications in gynecology.
    Garcia JE
    Clin Obstet Gynecol; 1993 Sep; 36(3):719-26. PubMed ID: 8403618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant LH in ovarian stimulation.
    Caglar GS; Asimakopoulos B; Nikolettos N; Diedrich K; Al-Hasani S
    Reprod Biomed Online; 2005 Jun; 10(6):774-85. PubMed ID: 15970010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum luteinizing hormone in patients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcome.
    Bosch E; Escudero E; Crespo J; Simón C; Remohí J; Pellicer A
    Fertil Steril; 2005 Nov; 84(5):1529-32. PubMed ID: 16275263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum Stem Cell Factor Assay in Elderly Poor Responder Patients Undergoing IVF: A New Biomarker to Customize Follicle Aspiration Cycle by Cycle.
    Gizzo S; Quaranta M; Andrisani A; Bordin L; Vitagliano A; Esposito F; Venturella R; Zicchina C; Gangemi M; Noventa M
    Reprod Sci; 2016 Jan; 23(1):61-8. PubMed ID: 26156851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FSH, LH, PRL and E2 levels in follicular fluid and serum of patients undergoing follicle stimulation with different protocols for IVF.
    Shin MT; Chu TY; Hsu CH; Yu MH; Chang JS; Sun D; Lao ZH; Wu KT; Lee CK; Yang CL
    Asia Oceania J Obstet Gynaecol; 1988 Jun; 14(2):227-32. PubMed ID: 3145732
    [No Abstract]   [Full Text] [Related]  

  • 37. A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in-vitro fertilization patients.
    Jansen CA; van Os HC; Out HJ; Coelingh Bennink HJ
    Hum Reprod; 1998 Nov; 13(11):2995-9. PubMed ID: 9853844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum and follicular endocrine profile is different in modified natural cycles than in cycles stimulated with gonadotropin and gonadotropin-releasing hormone antagonist.
    Jancar N; Virant-Klun I; Bokal EV
    Fertil Steril; 2009 Dec; 92(6):2069-71. PubMed ID: 19815198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Steroid and protein hormone concentrations in serum and follicular fluid after stimulation for in vitro fertilization].
    Zech H; Weiss P; Fritzsche H; Zech J; Daxenbichler G
    Geburtshilfe Frauenheilkd; 1992 Aug; 52(8):483-6. PubMed ID: 1397945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.